Summit Therapeutics Inc. - COM (SMMT)

Historical Portfolio Holders from Q3 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
48.3 M
Holdings value Q1 2024
$200 M
Value change Q1 2024
+$70.1 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
93
Number of buys Q1 2024
52
Number of sells Q1 2024
-35
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
86627T108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 48.3 M $200 M +$70.1 M $4.14 93
2023 Q4 31.6 M $82.5 M +$1.8 M $2.61 91
2023 Q3 32.3 M $60.3 M -$5.25 M $1.87 88
2023 Q2 34.9 M $87.5 M +$36.5 M $2.51 95
2023 Q1 21 M $36.8 M +$22.2 M $1.75 84
2022 Q4 8 M $34 M +$22.2 M $4.25 56
2022 Q3 3.13 M $3.72 M -$5.15 M $1.19 35
2022 Q2 8.43 M $8.43 M -$4.22 M $1.00 31
2022 Q1 10.6 M $26 M -$224 K $2.45 42
2021 Q4 10.7 M $28.7 M -$162 K $2.69 47
2021 Q3 10.7 M $53.8 M -$1.09 M $5.01 50
2021 Q2 11 M $82.4 M +$14.1 M $7.46 53
2021 Q1 9.28 M $54.5 M +$1.36 M $5.87 36
2020 Q4 8.51 M $40 M -$70.1 K $4.70 28
2020 Q3 7.75 M $26.7 M +$26.7 M $3.44 14